Skip to content

Clinical trials

Phase 2 Congenital Abnormalities trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Congenital Abnormalities Phase: Phase 2 Clear all

156 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20018
20028
20036
200412
20059
200616
200710
200815
20097
20109
20118
20124
20136
20146
20151
20171
20191
20202
20212
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed109
Terminated30
Unknown status6
Withdrawn6
Active, not recruiting3
Suspended1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fred Hutchinson Cancer Center26
National Cancer Institute (NCI)22
Case Comprehensive Cancer Center11
City of Hope Medical Center7
Roswell Park Cancer Institute7
Masonic Cancer Center, University of Minnesota5
Memorial Sloan Kettering Cancer Center4
Northside Hospital, Inc.4
SWOG Cancer Research Network4
Alliance for Clinical Trials in Oncology3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Congenital Abnormalities156
Leukemia, Myeloid, Acute126
Leukemia77
Precursor Cell Lymphoblastic Leukemia-Lymphoma62
Leukemia, Lymphocytic, Chronic, B-Cell54
Leukemia, Myeloid, Accelerated Phase54
Myeloproliferative Disorders54
Myelodysplastic Syndromes53
Leukemia, Myeloid, Chronic-Phase51
Lymphoma, Follicular51

Trials

Showing 26 to 50 of 156. Each trial links to its page on Pharma Observatory.

56 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.